ASX - By Stock
|
RAP |
Re:
What to expect if Pfizer's takeover fails
|
|
Erictheeel
|
108 |
23K |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
108
|
23K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Erictheeel
|
466 |
161K |
15 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
466
|
161K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Psychological Conditioning
|
|
Erictheeel
|
131 |
27K |
25 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
131
|
27K
|
25
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Erictheeel
|
62 |
17K |
16 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
62
|
17K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Tony's Conflict of Interest and the BoDs
|
|
Erictheeel
|
18 |
6.4K |
11 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
18
|
6.4K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Psychological Conditioning
|
|
Erictheeel
|
131 |
27K |
26 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
131
|
27K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
What to expect if Pfizer's takeover fails
|
|
Erictheeel
|
108 |
23K |
6 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
108
|
23K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Erictheeel
|
446 |
98K |
8 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
446
|
98K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Study shows efficacy of ResAppDx use with masks
|
|
Erictheeel
|
12 |
4.4K |
11 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
12
|
4.4K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Erictheeel
|
466 |
161K |
15 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
466
|
161K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Erictheeel
|
446 |
98K |
42 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
446
|
98K
|
42
|
|
ASX - By Stock
|
RAP |
Tony's Conflict of Interest and the BoDs
|
|
Erictheeel
|
18 |
6.4K |
46 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
18
|
6.4K
|
46
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
Erictheeel
|
123 |
36K |
24 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Computershare Calling - Pfizer feedback
|
|
Erictheeel
|
96 |
34K |
36 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
96
|
34K
|
36
|
|
ASX - By Stock
|
NTI |
Re:
Ann: BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD
|
|
Erictheeel
|
33 |
11K |
3 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
33
|
11K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Erictheeel
|
425 |
126K |
38 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
126K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Erictheeel
|
1.8K |
632K |
5 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
1.8K
|
632K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Erictheeel
|
687 |
256K |
3 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
687
|
256K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Erictheeel
|
687 |
256K |
13 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
256K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
Erictheeel
|
36 |
14K |
28 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
36
|
14K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race receives Human Ethics AML Trial Approval
|
|
Erictheeel
|
32 |
15K |
7 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
32
|
15K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Erictheeel
|
3.3K |
2.5M |
20 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
20
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Erictheeel
|
1.0K |
296K |
36 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
1.0K
|
296K
|
36
|
|
ASX - By Stock
|
RAP |
Re:
what is it going to take to see .30 again ?
|
|
Erictheeel
|
50 |
18K |
4 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
50
|
18K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
COVID-19 Saliva Test for Olympics
|
|
Erictheeel
|
114 |
33K |
4 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
114
|
33K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
Erictheeel
|
172 |
49K |
2 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
172
|
49K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
Erictheeel
|
172 |
49K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
172
|
49K
|
3
|
|
ASX - By Stock
|
RAP |
Board members - Its time to buy or go
|
|
Erictheeel
|
172 |
49K |
32 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
172
|
49K
|
32
|
|
ASX - By Stock
|
DEV |
Re:
Ann: Extensive copper-gold soil anomaly at Junee Project, NSW
|
|
Erictheeel
|
51 |
16K |
4 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
51
|
16K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Appointment of Joint Company Secretary
|
|
Erictheeel
|
15 |
6.9K |
5 |
05/12/20 |
05/12/20 |
ASX - By Stock
|
15
|
6.9K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
ADO Analysis
|
|
Erictheeel
|
4.3K |
2.5M |
1 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
4.3K
|
2.5M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Peter van der Made Presents AKIDA at BIC
|
|
Erictheeel
|
68 |
28K |
7 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
68
|
28K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
1 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
108
|
36K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
Erictheeel
|
29K |
14M |
7 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
29K
|
14M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
Erictheeel
|
392 |
158K |
12 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
3 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
108
|
36K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
13 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
108
|
36K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
4 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
108
|
36K
|
4
|
|
ASX - By Stock
|
ADO |
Re:
Covid 19 Testmakers lost 38bn USD market value on Biontech vaccine announcement
|
|
Erictheeel
|
120 |
28K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
120
|
28K
|
1
|
|
ASX - By Stock
|
ARR |
Re:
Charts
|
|
Erictheeel
|
120 |
41K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
120
|
41K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
Erictheeel
|
392 |
158K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
392
|
158K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
17 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
108
|
36K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Erictheeel
|
17K |
6.7M |
6 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Erictheeel
|
108 |
36K |
20 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
108
|
36K
|
20
|
|
ASX - By Stock
|
ADO |
Re:
Covid 19 Testmakers lost 38bn USD market value on Biontech vaccine announcement
|
|
Erictheeel
|
120 |
28K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
120
|
28K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
Erictheeel
|
29K |
14M |
4 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
29K
|
14M
|
4
|
|